N/A
Completed N=106
Impact of SpHb Monitoring on Transfusion
Source: ClinicalTrials.gov NCT01906515 ↗Enrolled (actual)
106
Serious AEs
0.0%
Results posted
Jan 2014
Primary outcomePrimary: RBC Transfusions Per Subject Receiving a Transfusion — 2.3; 3.9 units — p=<0.01
Summary
Continuous and noninvasive hemoglobin (SpHb) monitoring provides clinicians with real-time trending of changes or lack of changes in hemoglobin, which has the potential to alter red blood cell (RBC) transfusion decision making. The objective of this study was to evaluate the impact of SpHb monitoring on RBC transfusions in high blood loss surgery. The investigators hypothesize that SpHb will improve blood transfusion practice in the for of change the number of blood unit per patient and improve the outcome regards the time to take decision of transfusion trigger.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY RBC Transfusions Per Subject Receiving a Transfusion |
2.3; 3.9 | <0.01 sig |
| PRIMARY The Effect of SpHb on Transfusion Timeline |
9.2; 50.2 | <0.001 sig |
| SECONDARY SpHb Absolute and Trend Accuracy |
— | — |
Eligibility Criteria
Inclusion Criteria
- ASA 1, 2 patients from 15 to 60 years old scheduled for neurosurgical procedure
Exclusion Criteria
- Exclusion criteria included significant liver or renal disease, coagulopathy, pregnancy, anemia, and patients scheduled for procedures with excepted low blood loss.
Data sourced from ClinicalTrials.gov (NCT01906515). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.